Priya Singhal
Corporate Officer/Principal en BIOGEN INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Priya Singhal is currently the Chief Medical Officer at Biogen, Inc. She previously worked as the Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012.
She also held a position as the Head-Research & Development at Zafgen, Inc. Dr. Singhal holds a doctorate degree from the University of Mumbai and a graduate degree from Harvard T.H.
Chan School of Public Health.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOGEN INC.
0.00% | 02/04/2024 | 4 886 ( 0.00% ) | 1 M $ | 31/03/2024 |
Cargos activos de Priya Singhal
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 02/10/2023 |
Antiguos cargos conocidos de Priya Singhal.
| Empresas | Cargo | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 01/01/2012 |
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Priya Singhal.
| University of Mumbai | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Priya Singhal
